The recommendations now also contain a decision on suitable H3N2 strains for inactivated influenza vaccines. The list of reagents for vaccine standardisation has also been updated. Details such as the specific virus strains to be included, are available in the updated 2019/2020 recommendations issued by EMA’s Biologics Working Party (BWP) ad-hoc Influenza Working Group.
